Covered recipient · General Payments record
JAMIE LANGENHAN ABBOTT
Allopathic & Osteopathic Physicians Dermatology
General Payments · PY2019–2024
$3,029.89
- Reported across 173 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $615.99 | 33 |
| Education | $8.45 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $309.89 | 19 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $48.72 | 2 |
| Janssen Biotech, Inc. | $47.72 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $43.89 | 2 |
| UCB, Inc. | $40.09 | 2 |
| E.R. Squibb & Sons, L.L.C. | $32.27 | 2 |
| GENZYME CORPORATION | $28.38 | 1 |
| Lilly USA, LLC | $22.14 | 1 |
| Galderma Laboratories, L.P. | $21.41 | 1 |
| Arcutis Biotherapeutics, Inc. | $15.34 | 1 |
| PFIZER INC. | $14.59 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (34)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $5.52 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103162780 | CMS |
| ABBVIE INC. | $18.70 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103162782 | CMS |
| ABBVIE INC. | $15.74 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103162784 | CMS |
| ABBVIE INC. | $15.90 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103162786 | CMS |
| ABBVIE INC. | $18.33 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103162788 | CMS |
| ABBVIE INC. | $13.22 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103162790 | CMS |
| ABBVIE INC. | $14.57 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103162792 | CMS |
| ABBVIE INC. | $8.45 | 05/10/2024 | Education | Undisputed | 01/23/2026 | 1104193838 | CMS |
| ABBVIE INC. | $19.91 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103162794 | CMS |
| ABBVIE INC. | $29.23 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103162796 | CMS |
| ABBVIE INC. | $21.75 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103162798 | CMS |
| ABBVIE INC. | $24.64 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103162800 | CMS |
| ABBVIE INC. | $9.24 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103162802 | CMS |
| ABBVIE INC. | $18.08 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103162804 | CMS |
| ABBVIE INC. | $18.81 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103162806 | CMS |
| ABBVIE INC. | $11.87 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103162808 | CMS |
| ABBVIE INC. | $21.95 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103162810 | CMS |
| ABBVIE INC. | $17.26 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103162812 | CMS |
| ABBVIE INC. | $6.72 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103162814 | CMS |
| Arcutis Biotherapeutics, Inc. | $15.34 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1121051555 | CMS |
| E.R. Squibb & Sons, L.L.C. | $15.69 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101719738 | CMS |
| E.R. Squibb & Sons, L.L.C. | $16.58 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101719870 | CMS |
| Galderma Laboratories, L.P. | $21.41 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145282263 | CMS |
| GENZYME CORPORATION | $28.38 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139761194 | CMS |
| Janssen Biotech, Inc. | $23.30 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078267641 | CMS |
| Janssen Biotech, Inc. | $24.42 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078267329 | CMS |
| Lilly USA, LLC | $22.14 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135025392 | CMS |
| Novartis Pharmaceuticals Corporation | $20.00 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086643895 | CMS |
| Novartis Pharmaceuticals Corporation | $23.89 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086643897 | CMS |
| PFIZER INC. | $14.59 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131170813 | CMS |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $23.23 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152156840 | CMS |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $25.49 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152156842 | CMS |
| UCB, Inc. | $16.93 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143473029 | CMS |
| UCB, Inc. | $23.16 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143473035 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.